The stock of Acasti Pharma Inc (CVE:ACST) is a huge mover today! About 20,760 shares traded hands or 987.48% up from the average. Acasti Pharma Inc (CVE:ACST) has risen 6.00% since October 30, 2016 and is uptrending. It has outperformed by 0.74% the S&P500.
The move comes after 6 months positive chart setup for the $29.70 million company. It was reported on Nov, 29 by Barchart.com. We have $2.60 PT which if reached, will make CVE:ACST worth $1.19M more.
More recent Acasti Pharma Inc (CVE:ACST) news were published by: Marketwatch.com which released: “Acasti Pharma Inc.” on November 28, 2016. Also Quotes.Wsj.com published the news titled: “News Acasti Pharma Inc.ACST” on January 08, 2013. 247Wallst.com‘s news article titled: “Acasti Pharma Share Gains Massive in Percentage Terms, Tiny in Dollars” with publication date: September 14, 2016 was also an interesting one.
Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The company has a market cap of $29.70 million. The Firm is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. It currently has negative earnings. The Firm is involved in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.